Ginkgo Bioworks Announces Participation in Goldman Sachs 43rd Annual Global Healthcare Conference

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) will participate in Goldman Sachs' 43rd Annual Global Healthcare Conference on June 15, 2022, at 10:40 a.m. PT. The company focuses on cell programming, providing a platform for biotechnology applications across various sectors including pharmaceuticals and agriculture. Ginkgo has also supported COVID-19 efforts such as pooled testing and vaccine optimization. Further details, including a webcast link, will be available on their investor relations website.

Positive

• Participation in a prominent healthcare conference may enhance visibility and investor interest.
• Ginkgo Bioworks is actively involved in COVID-19 response efforts, which can improve public perception and support.

Negative

• None.

BOSTON, June 10, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in Goldman Sachs' 43^rd Annual Global Healthcare Conference, on June 15, 2022, at 10:40 a.m. PT.

Further details, a webcast link, and a replay of the presentation, if available, will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com 

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-goldman-sachs-43rd-annual-global-healthcare-conference-301566039.html

SOURCE Ginkgo Bioworks

FAQ

When is Ginkgo Bioworks participating in the Goldman Sachs healthcare conference?

Ginkgo Bioworks is scheduled to participate in the Goldman Sachs' 43rd Annual Global Healthcare Conference on June 15, 2022, at 10:40 a.m. PT.

What is the stock symbol for Ginkgo Bioworks?

The stock symbol for Ginkgo Bioworks is DNA.

What industries does Ginkgo Bioworks serve?

Ginkgo Bioworks serves various industries, including pharmaceuticals, agriculture, and industrial chemicals.

How has Ginkgo Bioworks contributed to COVID-19 efforts?

Ginkgo Bioworks has been involved in efforts such as K-12 pooled testing, optimizing vaccine manufacturing, and therapeutics discovery.